Feedback / Questions
Epoladerm (1.3% diclofenac epolamine) - Virpax Pharma
"Virpax® Successfully Completes Preclinical Dermal Safety Studies for Epoladerm™ https://t.co/cu6AHblLSv"
(@NewsFromBW)
Jan 18, 2022
https://twitter.com/NewsFromBW/status/1483440890844626945
Jan 18, 2022
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious